Lee, J., Liu, H., Pearson, T., Iwase, T., Fuson, J., Lalani, A. S., . . . Ueno, N. T. (2021). PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening. Biomedicines.
Chicago ZitierstilLee, Jangsoon, et al. "PI3K and MAPK Pathways As Targets for Combination With the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC By Kinome RNAi Screening." Biomedicines 2021.
MLA ZitierstilLee, Jangsoon, et al. "PI3K and MAPK Pathways As Targets for Combination With the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC By Kinome RNAi Screening." Biomedicines 2021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.